M
Melvin D. Yahr
Researcher at City University of New York
Publications - 9
Citations - 610
Melvin D. Yahr is an academic researcher from City University of New York. The author has contributed to research in topics: Parkinson's disease & Levodopa. The author has an hindex of 8, co-authored 9 publications receiving 595 citations.
Papers
More filters
Journal ArticleDOI
Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.
Journal ArticleDOI
Postencephalitic parkinsonism – a review
TL;DR: The presence of oligoclonal IgG bands in the CSF of suspected cases and the finding of chronic active lesions in the brain tissue at autopsy suggests a viral etiology of Parkinson's disease.
Journal ArticleDOI
Antineurofilament antibodies in postencephalitic and idiopathic Parkinson's disease
TL;DR: The use of cryostat-frozen longitudinal sections of normal rat spinal cord as a substrate has been confirmed to be an effective, reproducible and simple procedure for the detection of antineurofilament antibodies in human sera by indirect immunofluorescence.
Journal ArticleDOI
Treatment of Parkinson's disease in early and late phases. Use of pharmacological agents with special reference to deprenyl (selegiline).
TL;DR: Deprenyl's major usefulness has been demonstrated in patients under treatment with levodopa which has become complicated by fluctuating responses – particularly those of the end‐start‐dose variety.
Journal ArticleDOI
Ocular dyskinesias in patients with Parkinson's disease treated with levodopa.
TL;DR: Dyskinetic eye movements found in patients with Parkinson's disease who were receiving levodopa and dopa decarboxylase inhibitors were smooth, slow, “to‐and‐fro” ocular deviations of large amplitude, and generally appeared in conjunction with involuntary body and limb movements but could occur alone.